SVB Leerink Upgrades Agios Pharma (AGIO) to Outperform

July 27, 2022 7:06 AM EDT Send to a Friend
SVB Leerink analyst Andrew Berens upgraded Agios Pharma (NASDAQ: AGIO) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login